This is one reason clinicians review the full medication list before making changes
As a once-weekly injectable, Zepbound is recognized for targeting both GLP-1 and GIP receptors, achieving the highest weight loss efficacy among current offerings
GLP-1 medications may be recommended for adults struggling to lose weight through traditional methods like diet and exercise alone
Back Underwerth, D (June 2017) 'How does obesity cause cancer?', MD Anderson Center
Yet with preclinical trials ongoing, the list of insurance-approved uses could soon expand to include sleep apnea (which can be weight-related), Parkinsons, dementia, and more
Two new studies shed light on distinct but significant clinical questions, one reshaping how doctors might approach early type 2 diabetes treatment, and another offering the clearest biological explanation for why some long Covid patients develop debilitating neurological symptoms